Sales exec indicted in DOJ’s generic pharma probe

Ben Remaly

05 February 2020

A federal grand jury has indicted a former Taro Pharmaceuticals executive on charges of participating in two conspiracies to fix prices, rig bids and allocate customers for generic pharmaceuticals.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Ben Remaly

View full biography

Author | Editor, GCR USA

[email protected]

Tipline

Could have been an email: The Tipline for 1 December 2023
The Federal Trade Commission and House Judiciary Committee appear to be stuck in a stalemate regardless of whether their quarrel occurs in letters or public hearings. Pressed by Republican lawmakers about the FTC’s responses (or lack thereof) to various document demands, the commission’s director of congressional relations had very little to say. “I’m not able to provide that information today, but we're happy to continue talking to your staff,” Jeanne Bumpus said.
Take two: The Tipline for 30 November 2023
Lights, in camera, action: The Tipline for 29 November 2023